OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998–2016
暂无分享,去创建一个
[1] R. Afshari,et al. Effects of licence change on prescribing and poisons enquiries for antipsychotic agents in England and Scotland. , 2003, British journal of clinical pharmacology.
[2] Manuela Lippek. National Health Service (NHS) in England , 2004 .
[3] S. Pearce,et al. Trends in thyroid hormone prescribing and consumption in the UK , 2009, BMC public health.
[4] E. Dietrich. Effects of the National Institute for Health and Clinical Excellence's technology appraisals on prescribing and net ingredient costs of drugs in the National Health Service in England , 2009, International Journal of Technology Assessment in Health Care.
[5] T. Coleman,et al. Prescribing of smoking cessation medication in England since the introduction of varenicline. , 2011, Addiction.
[6] T. Coleman,et al. The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England. , 2011, Addiction.
[7] J. Moncrieff,et al. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. , 2012, The British journal of psychiatry : the journal of mental science.
[8] M. May,et al. Effects of MHRA drug safety advice on time trends in prescribing volume and indices of clinical toxicity for quinine. , 2013, British journal of clinical pharmacology.
[9] R. Quinton,et al. A UK epidemic of testosterone prescribing, 2001–2010 , 2013, Clinical endocrinology.
[10] A. Connor,et al. Glaucoma prescribing trends in England 2000 to 2012 , 2014, Eye.
[11] R. Fitzpatrick,et al. Assessing the impact of NICE guidance on the prescribing of hormonal treatments of breast cancer in England. , 2015, Journal of evaluation in clinical practice.
[12] P. Aveyard,et al. Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision. , 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.